3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.

TCRX Insider Trading (Tscan Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $97,621.14
Insider Selling (Last 12 Months): $0.00

Tscan Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Tscan Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tscan Therapeutics Share Price & Price History

Current Price: $5.05
Price Change: Price Increase of +0.49 (10.75%)
As of 01/14/2022 01:00 AM ET

This chart shows the closing price history over time for TCRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
New "Super Battery" That Will Drive the $3 Trillion EV Market
GM, Ford, Toyota, BMW, Honda, Nissan and Volkswagen are scrambling to get this technology inside their vehicles.

This $2 company with key patents is doing deals right now.
Click to learn more.

Tscan Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/23/2021Zoran ZdraveskiInsiderBuy4,716$7.48$35,275.68View SEC Filing Icon  
9/21/2021Brian M. SilverCFOBuy5,000$6.32$31,600.00View SEC Filing Icon  
9/20/2021Gavin MacBeathInsiderBuy4,943$6.22$30,745.46View SEC Filing Icon  
See Full Table
Insider Trading at Tscan Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Tscan Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Tscan Therapeutics (NASDAQ:TCRX)

37.87% of Tscan Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TCRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tscan Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2021Schonfeld Strategic Advisors LLC22,200$0.19M0.0%N/A0.093%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP13,000$0.11M0.0%N/A0.054%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP22,817$0.19M0.0%N/A0.095%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP139,566$1.16M0.0%N/A0.582%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC30,240$0.25M0.0%N/A0.126%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC11,922$99K0.0%N/A0.050%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley28,236$0.24M0.0%N/A0.118%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP75,000$0.63M0.0%N/A0.313%Search for SEC Filing on Google Icon
11/12/2021DC Investments Management LLC35,563$0.30M0.6%N/A0.148%Search for SEC Filing on Google Icon
11/12/2021DC Funds LP630,000$5.25M20.6%N/A2.629%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC12,786$0.11M0.0%N/A0.053%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.11,531$96K0.0%N/A0.048%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,500,577$12.52M0.0%N/A6.261%Search for SEC Filing on Google Icon
11/9/2021Monashee Investment Management LLC100,000$0.83M0.2%N/A0.417%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tscan Therapeutics logo
TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.
Read More on Tscan Therapeutics

Today's Range

Now: $5.05
Low: $4.34
High: $5.15

50 Day Range

MA: $6.25
Low: $4.20
High: $9.00

52 Week Range

Now: $5.05
Low: $4.18
High: $14.71

Volume

26,206 shs

Average Volume

24,900 shs

Market Capitalization

$120.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Tscan Therapeutics?

Tscan Therapeutics' top insider shareholders include:
  1. Brian M Silver (CFO)
  2. Gavin Macbeath (Insider)
  3. Zoran Zdraveski (Insider)
FREE DOWNLOAD: Simple Options Trading For Beginners
Avoid the account-crippling mistakes most rookies make with options trading...

...by using the simple steps to safely and profitably growing your account revealed in this free report.

(It's a quick read.)
Click to download.